Eton Drug Patent Portfolio
Eton owns 1 orange book drug protected by 3 US patents Given below is the list of Eton's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9649280 | Composition comprising hydrocortisone | 12 May, 2034 | Active |
| US9675559 | Treatment of adrenal insufficiency | 10 Jan, 2033 | Active |
| US9717740 | Treatment of adrenal insufficiency | 19 Nov, 2032 | Active |
Latest Legal Activities on Eton's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Eton.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 20 Jan, 2021 | US9717740 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 25 Nov, 2020 | US9675559 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 04 Nov, 2020 | US9649280 |
| Mail O.P. Petition Decision | 08 Sep, 2017 | US9675559 |
|
Email Notification
Critical
| 08 Sep, 2017 | US9675559 |
|
Mail-Petition Decision - Dismissed
Critical
| 07 Sep, 2017 | US9675559 |
| O.P. Petition Decision | 06 Sep, 2017 | US9675559 |
|
Petition Decision - Dismissed
Critical
| 06 Sep, 2017 | US9675559 |
| Petition Entered | 10 Aug, 2017 | US9675559 |
|
Recordation of Patent Grant Mailed
Critical
| 01 Aug, 2017 | US9717740 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 01 Aug, 2017 | US9717740 |
|
Email Notification
Critical
| 21 Jul, 2017 | US9717740 |
|
Application ready for PDX access by participating foreign offices
Critical
| 20 Jul, 2017 | US9717740 |
|
PG-Pub Issue Notification
Critical
| 20 Jul, 2017 | US9717740 |
|
Email Notification
Critical
| 13 Jul, 2017 | US9717740 |
Eton's Family Patents
Eton drugs have patent protection in a total of 24 countries. It's US patent count contributes only to 6.0% of its total global patent coverage. Click
below to unlock the full patent family tree.
Eton Drug List
Given below is the complete list of Eton's drugs and the patents protecting them.
1. Alkindi Sprinkle
Alkindi Sprinkle is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9649280 | Composition comprising hydrocortisone |
12 May, 2034
(9 years from now)
| Active |
| US9675559 | Treatment of adrenal insufficiency |
10 Jan, 2033
(8 years from now)
| Active |
| US9717740 | Treatment of adrenal insufficiency |
19 Nov, 2032
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alkindi Sprinkle's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List